MRI contrast agent developer Epix Pharmaceuticals has hired Sheila DeWitt, Ph.D., as vice president of business development and strategic planning.
DeWitt has almost 20 years of scientific and business-leadership experience, most recently serving as a consultant to the biotech industry, according to the Cambridge, MA-based firm.
By AuntMinnie.com staff writers
April 5, 2005
Related Reading
Bracco dispute trims Epix revenues, February 18, 2005
Epix hit with class-action lawsuit, January 28, 2005
Epix gets approvable letter, January 14, 2005
Epix shows Q3 downturn, October 27, 2004
Epix Medical changes name, September 8, 2004
Copyright © 2005 AuntMinnie.com
